View in EDS PDF Full Text

Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB).

Saved in:
Bibliographic Details
Title: Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB).
Authors: Azpilikueta A; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain., Bolaños E; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain., Lang V; Inbiomed Fundation, Fundation for Stem Cell Research, Mesechymal Stem Cell Laboratory, San Sebastian, Spain., Labiano S; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain., Aznar MA; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain., Etxeberria I; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain., Teijeira A; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain., Rodriguez-Ruiz ME; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.; University Clinic, University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain., Perez-Gracia JL; University Clinic, University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain., Jure-Kunkel M; Bristol-Myers Squibb, Lawrenceville, New Jersey, USA., Zapata JM; Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, Madrid, Spain., Rodriguez MS; Institut des Technologies Avancées en sciences du Vivant (ITAV), Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, UPS, Tolouse, France., Melero I; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.; University Clinic, University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Centro de Investigación Biomedica en Red (CIBERONC), Madrid, Spain.
Source: Oncoimmunology [Oncoimmunology] 2017 Sep 21; Vol. 7 (1), pp. e1368605. Date of Electronic Publication: 2017 Sep 21 (Print Publication: 2017).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29296520
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Azpilikueta+A%22">Azpilikueta A</searchLink>; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Bolaños+E%22">Bolaños E</searchLink>; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Lang+V%22">Lang V</searchLink>; Inbiomed Fundation, Fundation for Stem Cell Research, Mesechymal Stem Cell Laboratory, San Sebastian, Spain.<br /><searchLink fieldCode="AU" term="%22Labiano+S%22">Labiano S</searchLink>; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Aznar+MA%22">Aznar MA</searchLink>; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Etxeberria+I%22">Etxeberria I</searchLink>; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Teijeira+A%22">Teijeira A</searchLink>; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Ruiz+ME%22">Rodriguez-Ruiz ME</searchLink>; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.; University Clinic, University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Perez-Gracia+JL%22">Perez-Gracia JL</searchLink>; University Clinic, University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Jure-Kunkel+M%22">Jure-Kunkel M</searchLink>; Bristol-Myers Squibb, Lawrenceville, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Zapata+JM%22">Zapata JM</searchLink>; Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez+MS%22">Rodriguez MS</searchLink>; Institut des Technologies Avancées en sciences du Vivant (ITAV), Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, UPS, Tolouse, France.<br /><searchLink fieldCode="AU" term="%22Melero+I%22">Melero I</searchLink>; Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.; University Clinic, University of Navarra and Instituto de Investigacion Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Centro de Investigación Biomedica en Red (CIBERONC), Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2017 Sep 21; Vol. 7 (1), pp. e1368605. <i>Date of Electronic Publication: </i>2017 Sep 21 (<i>Print Publication: </i>2017).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2162-4011 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29296520
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2017.1368605
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1368605
    Titles:
      – TitleFull: Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Azpilikueta A
      – PersonEntity:
          Name:
            NameFull: Bolaños E
      – PersonEntity:
          Name:
            NameFull: Lang V
      – PersonEntity:
          Name:
            NameFull: Labiano S
      – PersonEntity:
          Name:
            NameFull: Aznar MA
      – PersonEntity:
          Name:
            NameFull: Etxeberria I
      – PersonEntity:
          Name:
            NameFull: Teijeira A
      – PersonEntity:
          Name:
            NameFull: Rodriguez-Ruiz ME
      – PersonEntity:
          Name:
            NameFull: Perez-Gracia JL
      – PersonEntity:
          Name:
            NameFull: Jure-Kunkel M
      – PersonEntity:
          Name:
            NameFull: Zapata JM
      – PersonEntity:
          Name:
            NameFull: Rodriguez MS
      – PersonEntity:
          Name:
            NameFull: Melero I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 09
              Text: 2017 Sep 21
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-print
              Value: 2162-4011
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Oncoimmunology
              Type: main
ResultId 1